Jump to content

User:Olso5610/sandbox

From Wikipedia, the free encyclopedia

Summary[edit]

TMEM260 is a human gene encoding a transmembrane protein of uncharacterized function. TMEM260 is conserved in primates, other mammals, birds, reptiles, and fish. The gene contains a domain, DUF2723, conserved in bacteria and contains ten transmembrane regions.

Gene[edit]

TMEM260 is located on chromosome 14 on the q arm at 22.3. It begins at 56,955,072bp from pter and ends at 57,117,324bp pter. The encoded protein is 4,278bp long and 707 amino acids. Aliases include C14orf101, FLJ20392 (clone), and UPF0679 protein C14orf101.

Other genes in the neighborhood of TMEM260 include OTX2, PELI2, RPL36A1 a ribosomal protein, and LINC00520 a long intergenic non-protein coding RNA.


Homology[edit]

Orthologs of TMEM260 are found mainly in primates and other mammals such as the elephant and domestic dog. Homologs were identified in reptiles, birds,and fish. no orthologs were identified in invertebrates or drosophila. There are no paralogs of TMEM260. The 3'UTR especially was shown to be conserved. The 5'UTR was only conserved in primates.

Multiple sequence alignment of TMEM260 and select orthologs. Shaded to highlight amino acid conservation.

In the protein sequence, Valine 174, Threonine 313, and Serine 566 were all found to be unique to humans.


Protein[edit]

Primary Sequence[edit]

Using the program AceView[1] , 13 splice variants were identified to make proteins other than TMEM260. None are experimentally confirmed. AceView also concluded that TMEM260 was produced at 2.2 times the avergage in comparison to the splice variants.

Post-Translational Modifications[edit]

In comparison to normal proteins, TMEM260 is pretty insignificant. 22 phosphorylation sites were identified with NetPhos[2] : 14 Serines, 3 Threonines, 5 Tyrosines. NetNGlyc[3] predicted four glycosylated asparagines; found at positions 318, 407, 535, 568. Only one acetylation site, with a score of 0.513, was identified at amino acid 2.

Secondary Structure[edit]

TMEM260 was identified to have mainly an α-helix secondary structure with few and small β-sheets using the PSIPRED[4] server.

3° and 4° Structure[edit]

Using PHYRE2[5], similarly structure protein were found. Ranging from amino acids 19-441, PHYRE2 provided an oligosaccharyltransferase protein with 99.4% confidence. Another similar protein structure was found for amino acids 614-696. It was identified to be a tetratricopeptide repeat with a 51.3% confidence.

File:TMEM260 Structure Prediction - Oligosaccharide Transferase.png
Oligosaccharide transferase structure predicted for amino acids 19-441
File:TMEM260 Structure Prediction - Tetratricopeptide.png
Tetratricopeptide repeat structure predicted for amino acids 614-696

Expression[edit]

Attributed by multiple expression maps, TMEM260 is expressed at fairly high levels throughout the body; averaging around the 70 percentile. Expression in current studies is associated with genes in the neighborhood, such as OTX2.

A full gene expression of TMEM260 tested in multiple tissue types.
A full gene expression of TMEM260 tested in multiple tissue types.

Biochemistry and Function[edit]

Interacting Proteins[edit]

Currently no proteins have been identified and confirmed to interact with TMEM260.

Clinical Significance[edit]

Altered expression of TMEM260 has been found in studies of medulloblastomas [6] and ovarian carcinomas.[7] However, no single mutation or set of mutations has been linked to any specific disease at the present.

References[edit]

  1. ^ Thierry-Mieg, D. and Thierry-Mieg J. "AceView: a comprehensive cDNA-supported gene and transcripts annotation". Genome Bioloy.
  2. ^ Blom, N. (1999). "Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites". Journal of Molecular Biology. 5. 294 (5): 1351–1362. doi:10.1006/jmbi.1999.3310. PMID 10600390. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  3. ^ Grupta, R., Jung, E., and Brunak, S. "Prediction of N-glycosylation sites in human proteins". Center for Biological Sequence Analysis.{{cite web}}: CS1 maint: multiple names: authors list (link)
  4. ^ Buchan, D.W., Ward, S.M., Lobley, A.E., Nugent, T.C., Bryson, K., and Jones, D.T. "Protein annotation and modelling servers at University College London". University College London.{{cite web}}: CS1 maint: multiple names: authors list (link)
  5. ^ Kelley, L.A. and Sternberg, M.J.E. "PHYRE2". Protein structure prediction on the web: a case study using the Phyre server. Nature Protocols.{{cite web}}: CS1 maint: multiple names: authors list (link)
  6. ^ Boon, K. (1). "Genomic Amplification of Orthodenticle Homologue 2 in Medullablastomas". Cancer Research. 65 (703): 703–707. doi:10.1158/0008-5472.703.65.3. S2CID 2634567. {{cite journal}}: Check date values in: |date= and |year= / |date= mismatch (help); Unknown parameter |coauthors= ignored (|author= suggested) (help); Unknown parameter |month= ignored (help)
  7. ^ Sabatier, R. (June 2011). "A seven-gene prognostic model for platinum-treated ovarian cancer". British Journal of Cancer. 105 (2): 304–311. doi:10.1038/bjc.2011.219. PMC 3142802. PMID 21654678. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)CS1 maint: date and year (link)